ArticleEnvironmental toxicology and chemistry2025
Evaluating the WHO toxic equivalency factors of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls for applicability to amphibians using an in vitro Ah receptor transactivation assay.
Article in Environmental toxicology and chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The World Health Organization (WHO) coordinated an expert meeting to streamline ecological risk assessments for complex mixtures of dioxin-like compounds (DLCs) by establishing 2,3,7,8-tetrachlorodibenzo-p-dixoin (2,3,7,8-TCDD) equivalency factors (TEFs) for mammals, fishes, and birds. No TEFs exist for amphibians nor have any studies investigated whether the existing TEFs for mammals, fishes, or birds are suitable estimates of DLC potency for this taxon. Therefore, the objective of this study was to determine the relative potency (ReP) for DLCs to assess the need for amphibian-specific TEFs. A total of 15 DLCs in addition to 2,3,7,8-TCDD were assessed in a standardized in vitro transactivation assay using COS-7 cells transfected with an expression construct for the aryl hydrocarbon receptor 1 (AHR1) from Xenopus laevis, a model amphibian. Two AHR1 paralogs (AHR1α/ahr.L and AHR1β/ahr.S) are expressed in X. laevis with comparable patterns of expression and comparable sensitivity to activation by DLCs, which suggests that RePs are independent of the specific AHR1 paralog. Compared with the corresponding WHO TEFs, 73% of RePs generated in this study for X. laevis are within tenfold of the WHO TEFs for birds, which was more similar than comparisons to the WHO TEFs for mammals (33%) and fishes (33%). Three key amino acid residues (N325, A354, and A370) within the ligand binding domain of AHR1 are conserved at homologous positions in all 21 amphibian species with known AHR1 sequences, suggesting that RePs for X. laevis are likely applicable to most, if not all, other amphibians. Overall, this study suggests risk assessors can refer to WHO TEFs for birds when evaluating the toxicity of DLC mixtures to amphibians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.